Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer

Breast cancer is a leading type of malignant tumor in women; however, the immunotherapy in breast cancer is still underappreciated. In this study, we demonstrated that tumor necrosis factor receptor 2 (TNFR2) is highly expressed in both breast tumor tissue and tumor-infiltrating immunosuppressive CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Qiang, Shen, Qian, Tong, Jin, Huang, Liu, Cheng, Yi, Zhong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655985/
https://www.ncbi.nlm.nih.gov/pubmed/34900985
http://dx.doi.org/10.3389/fcell.2021.720472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655985/
https://www.ncbi.nlm.nih.gov/pubmed/34900985
http://dx.doi.org/10.3389/fcell.2021.720472

Ejemplares similares